Arthroplasty
AAOS 2015: No difference between intra-articular & intravenous TXA administration in TKA
150 patients undergoing total knee arthroplasty with tourniquet application were randomized to receive tranexamic acid either intravenously or intra-articularly. The purpose of this trial was to compare the safety and effectiveness of the two administration techniques. Drain output, limb swelling, total blood loss, and incidence of complications were evaluated up to 4 days postoperatively. The results demonstrated comparable outcomes between the two modes of administration, with no significant differences in any of the measured variables.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
